Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.1986 · 743 citations
2. 2Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.1986 · 2,883 citations
3. 3Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein.1984 · 1,255 citations
4. 4Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.1984 · 623 citations
5. 5Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.1986 · 700 citations